What are the Historical Developments and Current Growth Metrics of the Platelet Aggregation Devices Market?
The platelet aggregation devices market has seen considerable growth due to a variety of factors.
• The platelet aggregation devices market has experienced exponential growth in recent years. It will grow from $0.83 billion in 2024 to $1.05 billion in 2025, with a compound annual growth rate (CAGR) of 25.8%.
Growth is attributed to the rising prevalence of cardiovascular diseases, bleeding disorders, increased awareness of health diagnostics, and a higher number of surgical procedures.
What is the Forecasted Market Size and CAGR for the Platelet Aggregation Devices Market?
The platelet aggregation devices market is expected to maintain its strong growth trajectory in upcoming years.
• The platelet aggregation devices market is expected to grow to $2.59 billion by 2029, at a CAGR of 25.4%.
The market expansion is driven by the aging population, point-of-care testing demand, personalized medicine, regulatory support, and chronic disease prevalence. Key trends include AI integration in diagnostics, portable platelet aggregation devices, collaboration with healthcare providers, data analytics importance, and home-based diagnostics.
What Key Factors and Trends Are Driving The Growth Platelet Aggregation Devices Market?
The escalating prevalence of specific illnesses, known as target diseases, is predicted to propel the growth of the platelet aggregation systems market. These target diseases, including cancer, cardiovascular disorders, and diabetes, are key areas of concentration in prevention, diagnosis, and treatment due to their substantial health implications. Platelet aggregation tools aid in diminishing the prevalence of these diseases by facilitating efficient detection and management of thrombotic risks, thereby averting serious conditions like heart attacks and strokes in susceptible individuals. For instance, statistics from the International Agency for Research on Cancer (IARC), a France-based cancer specialist organization of the World Health Organization (WHO), in February 2024, revealed around 20 million fresh cancer cases and 9.7 million deaths in 2022. Projections indicate an alarming 77% rise to beyond 35 million new cases by 2050. Among these, lung cancer topped globally with 2.5 million new incidents (12.4%) followed by breast cancer in women (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%) and stomach cancer (970,000, 4.9%). Consequently, the escalating prevalence of such target ailments is fueling the expansion of the platelet aggregation systems market.
What Are The Market Segments In The Platelet Aggregation Devices Market?
The platelet aggregation devices market covered in this report is segmented –
1) By Product: Reagents, Systems, Consumables And Accessories
2) By Type: Four Channel, Dual Channel, Eight Channel
3) By Technology: Optical, Impedance, Other Technologies
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users
Subsegments:
1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents
2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems
3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits
Pre-Book The Platelet Aggregation Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Platelet Aggregation Devices Market?
Major players in the platelet aggregation devices market are shifting their attention to the creation of sophisticated solutions through the introduction of novel products such as the first platelet pooling set. This set is designed to secure the platelet supply in the U.S. and satisfy rising demands. A platelet pooling set is a unique medical tool utilized during plateletpheresis procedures to gather and concentrate platelets from various donors into a single unit for transfusion treatment. To illustrate, TERUMO BCT INC., a corporation from the U.S. that offers blood components and cellular technology, publicized the Food and Drug Administration's (FDA) approval of the IMUGARD WB Platelet Pooling Set in February 2023. The FDA is a federal agency operating within the United States. This set provides extended durability for platelets, FDA authorization for storage for up to seven days, and permits platelet recovery from whole blood contributions, thus increasing convenience and supply in the platelet aggregation devices market. This introduction marks a significant technological progression by fulfilling the necessity for enhanced platelet availability, more effective supply control, and sustaining the pressured U.S. platelet supply to accommodate the increasing demand in crucial medical procedures like chemotherapy and organ transplants.
Who Are the Key Players In The Platelet Aggregation Devices Market?
Major companies operating in the platelet aggregation devices market are:
• Roche Holding AG
• Cytiva (Danaher Corp.)
• Siemens Healthineers
• Sysmex Corporation
• WerfenLife S.A.
• Haemonetics Corporation
• Helena Laboratories Corporation
• Sarstedt AG & Co. KG
• Sekisui Diagnostics LLC
• Diagnostica Stago
• Accriva Diagnostics Holdings Inc.
• Drucker Diagnostics
• Sentinel CH. SpA
• ADInstruments
• Chrono-Log Corporation
• Bio/Data Corporation
• Haemochrom Diagnostica GmbH
• AggreDyne Inc.
• Hart Biologicals Ltd.
• Stago
What Are The Regional Insights Into The Platelet Aggregation Devices Market?
North America was the largest region in the platelet aggregation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
